5 source-based articles maintained by the HealthRX.com Editorial Team.
Showing 5 of 5 clinical reviews.
A deep look at the SURPASS-2 randomization design, blinding strategy, estimand framework, comparator choice, and statistical approach, and what each decision means for how you should read the headline result.
Deep dive into SURPASS-2 follow-up data on tirzepatide vs semaglutide 1 mg in type 2 diabetes, covering durability of A1C and weight effects, post-trial regression, and emerging safety signals.
A detailed breakdown of the SURPASS-2 trial results comparing tirzepatide vs semaglutide 1 mg in type 2 diabetes, including effect sizes, confidence intervals, secondary endpoints, and time-course patterns.
Deep-dive into SURPASS-2 pre-specified and post-hoc subgroup analyses comparing tirzepatide vs semaglutide 1 mg across age, sex, BMI, race, and baseline biomarkers in type 2 diabetes.
A plain-English deep dive into the SURPASS-2 trial comparing tirzepatide to semaglutide 1 mg in type 2 diabetes, covering methodology, results, limitations, and clinical implications.